Adapting treatments for adaptive immunity in ischaemic heart disease (2022)
Attributed to:
Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cvr/cvac074
PubMed Identifier: 35653594
Publication URI: http://europepmc.org/abstract/MED/35653594
Type: Journal Article/Review
Parent Publication: Cardiovascular Research
Issue: 9
ISSN: 0008-6363